KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Solid Tumors With HRAS Alterations · Non Small Cell Lung Cancer (NSCLC) · Colorectal Cancer (CRC) · Pancreatic Ductal Adenocarcinoma (PDAC) · Clear Cell Renal Cell Carcinoma (ccRCC) · Renal Cell Carcinoma (Kidney Cancer) · Non Clear Cell Renal Cell Carcinoma (nccRCC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona, United States

  • University of Arizona, Tucson, Arizona, United States

  • University of Southern California, Los Angeles, California, United States

    Contact: Study coordinator (Xiomara Menendez, RN) · Xiomara.Menendez@med.usc.edu · 323-865-3000
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (William Mills) · william.mills@cshs.org · 310-423-0102
  • UCLA Department of Medicine, Los Angeles, California, United States

    Contact: Study coordinator (Christopher Lim) · christopherlim@mednet.ucla.edu · 310-633-8400
  • Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States

  • AdventHealth Celebration, Celebration, Florida, United States

    Contact: Study coordinator (Amy Whitaker) · amy.whitaker@adventhealth.com
  • Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, United States

  • Florida Cancer Specialists, Sarasota, Florida, United States

    Contact: Study coordinator (Nancy Olsen) · nolsen@flcancer.com
  • University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

    Contact: Study coordinator (Mimi McKay) · 319-353-8155
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Kailene Sullivan, RN) · kailene_sullivan@dfci.harvard.edu
  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Bethany Adams, RN) · badams19@HFHS.ORG · 248-224-7345
  • Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Jessica Ley) · jcley@wustl.edu · 314-747-8092
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Mohammad Ghalib) · mhg68@cinj.rutgers.edu · 718-405-8515
  • Ohio State University, Columbus, Ohio, United States

  • OU Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Christina Caldwell) · Christina-Caldwell@ouhsc.edu · 405-271-8001
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Immunotherapy and Drug Development Center (IDDC) Referrals) · ClinicalResearchServicesHCCIDDC@upmc.edu
  • SCRI - Oncology Partners, Nashville, Tennessee, United States

    Study coordinator · 844-482-4812
  • UT Southwestern Simmons Cancer Center, Dallas, Texas, United States

    Contact: Study coordinator (Tian Zhang, MD) · Tian.Zhang@utsouthwestern.edu
  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ly M Nguyen) · lmnguyen1@mdanderson.org · (832) 794-3672
  • University of Wisconsin (Carbone Cancer Center), Madison, Wisconsin, United States

    Contact: Study coordinator (UW Carbone Cancer Center - Cancer Connect) · clinicaltrials@cancer.wisc.edu · 800-622-8922
  • Centre Leon Berard, Lyon, France

  • Oncologie médicale - Pitié-Salpêtrière, Paris, France

    Contact: Study coordinator (Marianne Veyri) · marianne.veyri@aphp.fr
  • Hopital Européen Georges Pompidou, Paris, France

    Contact: Study coordinator (Anna Farran) · anna.farran@aphp.fr
    Contact: Study coordinator (Clémentine Drain) · clementine.drain@aphp.fr
  • Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France

  • Charité - Universitätsmedizin Berlin, Berlin, Germany

  • Universitätsklinikum Ulm, Ulm, Germany

  • Universitätsklinikum Würzburg, Würzburg, Germany

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna, Italy

    Contact: Study coordinator (Serena Aloi) · serena.aloi@aosp.bo.it
    Contact: Study coordinator (Mirela Giordano) · mirela.giordano@aosp.bo.it
  • Fondazione Piemonte per l'Oncologia - IRCCs Candiolo, Candiolo, Italy

    Contact: Study coordinator (Vanesa Gregorc, MD) · Vanesa.gregorc@ircc.it
  • Istituto Nazionale Tumori IRCCS, Naples, Italy

  • Humanitas University, Rozzano, Italy

  • AOU Verona - Centro Ricerche Cliniche di Verona, Verona, Italy

    Contact: Study coordinator (Andrea Zivi, MD) · andrea.zivi@aovr.veneto.it
  • Hospital Universitari Vall d'Hebron, Barcelona, Spain

    Contact: Study coordinator (Paula Barranco) · paulabarranco@vhio.net
  • Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain

    Contact: Study coordinator (Mireia Llobet Busquets) · mllobetb@santpau.cat
    Contact: Study coordinator (Phase 1 Center) · IR_fases1onco@santpau.cat
  • Hospital HM Sanchinarro START Madrid-CIOCC, Madrid, Spain

    Contact: Study coordinator (Maria Garrido, RN) · maria.garrido@startmadrid.com
    Contact: Study coordinator (Esther Ordoñez) · esther.ordonez@startmadrid.com
  • Hospital Universitario Virgen del Rocío, Seville, Spain

    Contact: Study coordinator (Rosa María Ballesteros) · rballesteros.oncologiahuvr@gmail.com